Systemic necrotizing vasculitis in children is a rare but serious disorder. During the past 25 years, 121 children within this disease category have been referred to the Hospital for Sick Children, London (HSC). Classification is difficult but the largest subgroups identified were polyarteritis nodosa (PAN)-29 children and Kawasaki syndrome (KD)-42 children. In spite of modern therapy including steroids, cyclophosphamide, anti-platelet medication, plasma exchange, prostacyclin, high dose gamma globulin and cyclosporin, mortality remains high. Overall mortality for HSC patients was 12% (66% for pulmonary vasculitis, 21% for PAN, and 2% for KD). Recent advances are beginning to shed some light on the etiology and pathogenetic mechanisms involved in PAN and KD. There is now good evidence to support roles for platelet immune complex interactions, anti-neutrophil cytoplasmic antibodies, and anti-endothelial cell antibodies in the pathogenesis. It seems likely that, in KD at least, retroviruses may have an etiological role either by directly infecting endothelial cells or indirectly via T-cells, antibody, or immune complex formation.
Systemic necrotizing vasculitis is said to have been first recognized by Michaelis and Matani in 1755 (17) . A number of other accounts followed before Kussmaul and Maier's classic description of macroscopicpolyarteritis nodosa in 1866 (9) .Since then, there have been many subsequent reports predominantly relating to adults. Unfortunately, the literature is confusing since within it are descriptions of a wide range of conditions involving inflammation and necrosis of blood vesselsand only recently some serious attempt at classification. One such classification, based on Fauci's work (6) defines the following categories ofvasculitis: macroscopic polyarteritis; microscopic polyarteritis; Churg-Strauss syndrome (allergic granulomatosis and angiitis); Wegener's granulomatosis; skin-hypersensitivity vasculitis; and Kawasaki syndrome. PEDIATRIC EXPERIENCE In children, the situation is less clear since the pediatric literature is comparatively limited. How-*Addresscorrespondence to: Dr. Michael J. Dillon (5) . Pre-l 950 mortality of what was considered to be polyarteritis nodosa was extremely high. Royer reported 100%mortality in 11 children treated at the Hopital des Enfants Malades, Paris before steroids were available (22) . Recent literature has given a misleadingly good impression of survival in children (1, 16, 21) which conflicts with that at the HSC, London.
During the past 25 years, at least 121 children with disseminated necrotizing vasculitis have been seen at the HSC, excluding patients with Henoch Schonlein purpura, disseminated lupus erythematosus, juvenile chronic arthritis, dermatomyositis, mixed connective tissue disease, and scleroderma.
These data are outlined in Table I . Apart from the 29 children with classic polyarteritis nodosa and the 42 children with Kawsaki syndrome, there were 3 with Wegener's granulomatosis, 5 with systemic Behcets disease, 5 with vasculitis associated with an identifiable infective agent, 2 with mediastinal masses that were not examples of Wegener's granulomatosis and probably had Castleman's disease, 3 with pulmonary vasculitis, 9 with 'hypersensitiv- ity' vasculitis, 1 with giant cell arteritis, and 22 others that came into a miscellaneous group. It was interesting that Churg-Strauss syndrome patients were conspicuous by their absence in this experience.
In spite of modern therapeutic advances, including the use of steroids, cyclophosphamide, antiplatelet medication, plasma exchange, prostacyclin, high dose gamma globulin and cyclosporin A, mortality remains high for the necrotizing vasculitides. There was an overall mortality of 12% for the HSC patients, but for classic polyarteritis nodosa it was 21% and for those with pulmonary vasculitis, 66% (4). A much lower figure of 2% was obtained for Kawasaki syndrome and it is possible that this may decrease further with the introduction of high dose intravenous gamma globulin therapy early in the disease course, in addition to low dose aspirin with or without dipyridamole.
ETIOLOGY AND PATHOGENESIS
New developments are beginning to throw some light on the etiology and pathogenetic mechanisms involved in polyarteritis and Kawasaki syndrome. The roles of platelet immune complex interactions, anti-neutrophil antibodies, anti-endothelial cell antibodies, and retroviruses may be of considerable importance in the pathogenesis of these diseases.
PLATELET IMMUNE COMPLEX INTERACTIONS
In 1985 from the HSC, Levin et al (14) showed that in the circulation of patients with polyarteritis and Kawasaki syndrome, there was a platelet aggregating factor that caused aggregation of washed normal platelets that was not present in plasma from normal controls. It was also demonstrable in the laboratory that this aggregation could be prevented by the presence of prostacyclin.
There was a close correlation between titers of this platelet aggregatingmaterial and circulating IgG immune complexes detected by polyethylene glycol precipitation. In polyarteritis, IgA and IgM complexes were identified, in addition to IgG, and remained raised for at least 3-4 weeks.
In Kawasaki syndrome, all patients developed a thrombocytosis in the third week of the illness and the platelet count was significantly correlated with the subsequent development of coronary .artery aneurysms. The rise in the platelet count was associated with the appearance in the circulation of a factor that induced platelet aggregation,' and this factor seemed to parallel the levels of immune complexes identified in the circulation.
. These findings implied that there may be different mechanisms playing a part at different times in the Kawasaki syndrome patients' illness. An initial feverish phase, probably infective, is followed by an immune complex vasculitis that occurs when antibodies to the initiating agent appear in the circulation. The immune complexes aggregate platelets and induce the release of serotonin, events which could well play an important role in vessel wall damage.
ANTI-NEUTROPHIL ANTIBODIES
Recently, Lockwood et al (15) and Savage et al (24) published their findings ofcirculating anti-neutrophil antibodies detected by solid phase radioimmunoassay in adult patients with Wegener's granulomatosis and microscopic polyarteritis. Prior to this, others had shown similar antibodies to be present in segmental necrotizing glomerulonephritis (3) and in Wegener's granulomatosis (7, 20, 26) by indirect immunofluorescence techniques.
In conjunction with the Royal Postgraduate Medical School in London, anti-neutrophil antibodies have been measured in HSC patients with vasculitis and found to be increased in 3 children with Wegener's granulomatosis, in 3 of6 children with polyarteritis, and in 3 of 7 children with crescentic ne- phritis. Within this group of crescentic nephritic children, it is possible that the cause may be microscopic polyarteritis in those with antibodies.
'In addition, anti-neutrophil antibodies have been detected ip 7 of 9 patients with Kawasaki syndrome (23) . All had elevated IgM titers and 8 of9 elevated IgG titers. However, the binding by indirect immunofluorescence to normal neutrophils was different from that seen in adult systemic vasculitis.
These data suggest that antibodies to neutrophil antigens may be markers for common mechanisms of vascular injury in the vasculitides and that the nature and specificity ofthe antibody response may reflect different pathogenetic mechanisms.
ANTI-ENDOTHELIAL CELL ANTIBODIES
In parallel to this work in London, Leung et al (12) in Boston have identified IgM antibodies present in the acute phase of Kawasaki syndrome that lyse cultured vascular endothelial cells stimulated by gamma interferon. This effect was complementdependent and the antibodies were directed against an inducible monomorphic antigenic determinant, not a major histo-compatability antigen, present in gamma interferon-treated endothelial cells. This raises the Question ofwhether antibodies to gamma interferon-induced .endothelial antigens may also represent a general mechanism of vascular injury.
RETROVIRUSES
It is also known that in Kawasaki syndrome there are profound immunoregulatory abnormalities present in the acute phase (11, 13) , including generalized T-cell lymphocytopenia,' activation of circulating T4+ helper T-cells, decrease in circulating T8 suppressor cells, marked activation of B-cells, and raised spontaneous secretion of IgG and IgM. These data suggested the possibility that a lymphotropic agent such as a retrovirus might be implicated in the etiology and several studies now strongly support this theory.
Schulman and Rowley in 1986 (25) studied reverse transcriptase activity in supernatants from cocultivated peripheral mononuclear cells of Kawasaki patients. They found that 8 of 18 children showed reverse transcriptase activity suggestingthat a retroviral agent may be closely related to Kawasaki disease.
In the same year, Bums et al (2) reported their findings on polymerase activity in lymphocyte culture supernatants from patients with Kawasaki disease. These studies demonstrated a peak polymerase activity after 10-17 d of culture and the reverse transcriptase activity could be transmitted to another established T-cell line. These findingswere also consistent with the view that a retrovirus may be the causative agent in Kawasaki disease.
In 1987, Leung et al (10) presented data showing that peripheral blood mononuclear cells from patients with Kawasaki syndrome could transmit reverse transcriptase activity to human endothelial cells. This suggests that the virus associated with Kawasaki syndrome is. capable of infecting both T-lymphocytes and human endothelial cells accounting for the marked immunoregulatory abnormalities and the endothelial cell injury during the acute phase of the disease.
Moynahan (18) has postulated that, since retroviruses are not species specific, the infective agent in Kawasaki syndrome may be transmitted to humans from an animal source. He suggests that the domestic cat might be involved in transmission of the infectious agent to man via fleas.
SUMMARY OF POSSIBLE PATHOPHYSIOLOGICAL MECHANISMS
In an attempt to sum up these recent findings, a diagram outlining some of the possible pathophysiological mechanisms involved in systemic vasculitis is shown in Fig. 1 . Some form of antigenic exposure, perhaps retroviral, could result in circulating immune complex formation: If not cleared by the reticuloendothelial (RE) system, these will get deposited in vessel walls causing damage leading eventually to thrombosis and necrosis. These complexes may also induce platelet aggregation, and the inability ofthe platelets to be cleared by the reticuloendothelial system results in their numbers increasing and their deposition into vessel walls contributing to vessel damage and occlusion. Anti-neutrophil an- tibodies may be formed to antigenic determinants in the infectious agent that are also on neutrophils and vessel endothelial cells, with either immune complex formation or adherence of granulocytes to vessel walls with ensuing damage. Similarly, antiendothelial cell antibodies may be formed after gamma interferon influence on endothelial cells with direct damaging effects on the vessels. Superimposed on this, there is the real possibility that in Kawasaki disease, at least, retroviruses may be playing a role either by directly infecting endothelial cells or indirectly via T-cells with resulting damaging effects.
There is a great deal more work to do in this field but it is interesting and gratifying that some ofthese important observations are being made through the study of childhood vasculitic disease.
